AI-generated summary
This narrative review, based on current evidence and expert opinion, discusses possible uses of photobiomodulation for side effects of chemoradiation in head and neck cancer beyond oral mucositis. The authors propose candidate treatment parameters for conditions such as dermatitis, dysphagia and dry mouth to guide future studies. The authors state these parameters are intended for well-designed future research and are not yet established as effective.
- Who or what was studied
- Patients receiving chemoradiation therapy for head and neck cancer
- Wavelengths
- 633, 685, 780, 830 nm
- Limits stated in the abstract
- The paper is a narrative review based on current evidence and expert opinion, and the proposed parameters require testing in well-designed future studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 685 nm, 780-830 nm
- Power
- 150 mW
- Total energy
- 3 J
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Low-level laser therapy, Laser, Light-emitting diode, Oral mucositis, Wavelength, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.